Skip to main content

Advertisement

SpringerLink
Log in

Patient Education in the Drug Treatment of Psychiatric Disorders

Effect on Compliance and Outcome

  • Review Articles
  • Clinical Concepts
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Both drug therapy and psychosocial interventions have been shown to be effective treatments for psychiatric disorders. However, noncompliance with treatment regimens is a serious problem, and results in significant economic and psychosocial costs to the individual and society. Noncompliance can be caused by a number of factors, but can be positively affected by clinician-patient interactions and the patients’ knowledge of and readiness to undergo treatment. Patient preparedness in the form of education about treatment, in general, and medication, in particular, is likely to be associated with improved adherence to treatment, psychological well-being and quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bisbee CC. Patient education in psychiatric illness. J Orthomolec Psychiatry 1979; 8: 239–47

    Google Scholar 

  2. Anderson CM, Reiss DJ, Hogarty GE. Schizophrenia and the family: a practitioner’s guide to psychoeducation and management. New York: Guilford Press, 1986

    Google Scholar 

  3. Raskin A. A comparison of acceptors and resistors of drug treatment as an adjunct to psychotherapy. J Consult Clinic Psychol 1961; 25: 366

    Article  CAS  Google Scholar 

  4. Richards AD. Attitude and drug acceptance. Br J Psychiatry 1964; 110: 46–52

    Article  PubMed  CAS  Google Scholar 

  5. Gillum RF, Barsky AJ. Diagnosis and management of patient non-compliance. JAMA 1974; 223: 1563–7

    Article  Google Scholar 

  6. Keith SJ. Drugs: not the only treatment. Hosp Community Psychiatry 1982; 33: 793

    PubMed  CAS  Google Scholar 

  7. Diamond RJ. Enhancing medication use in schizophrenic patients. J Clin Psychiatry 1983; 44: 7–14

    PubMed  CAS  Google Scholar 

  8. Dow MG, Verdi MB, Sacco WP. Training psychiatric patients to discuss medication issues. Behav Modif 1991; 15: 3–21

    Article  PubMed  CAS  Google Scholar 

  9. Collins EJ, Monroe-Blum H. Pharmacological and psychosocial integration in the treatment of schizophrenia. Contemp Psychiatry 1992; 17: 4–8

    Google Scholar 

  10. Hogarty GE, Anderson CM, Reiss DJ, et al. Family psychoeducation, social skills training and maintenance chemotherapy in the aftercare of schizophrenia. Arch Gen Psychiatry 1986; 43: 633–42

    Article  PubMed  CAS  Google Scholar 

  11. Goldstein MJ. Psychological strategies for maximizing the effect of psychotropic medications for schizophrenia and mood disorders. Psychopharmacol Bull 1992; 28: 237–40

    PubMed  CAS  Google Scholar 

  12. Bentley KJ, Rosenson MK, Zito JM. Promoting medication compliance: strategies for working with families of mentally ill people. Soc Work 1990; 35: 274–7

    PubMed  CAS  Google Scholar 

  13. Fernando MLD, Velamour VR, Cooper AJ, et al. Some factors relating to satisfactory past discharges: community maintenance of chronic psychotic patients. Can J Psychiatry 1990; 35: 71–3

    PubMed  Google Scholar 

  14. Kazarian SS, Vanderheyden D. Family education of relatives of people with psychiatric disability: a review. Psychosoc Rehab 1992; 15: 67–84

    Google Scholar 

  15. Kazarian SS, Malia K. Working with the families of long-term patients: an expressed emotion perspective. In: Persad E, Kazarian SS, Joseph LW, editors. The mental hospital in the 21st century. Toronto: Wall & Emerson Inc., 1992: 91–106

    Google Scholar 

  16. Applebaum P. The right to refuse treatment with antipsychotic medications: retrospect and prospect. Am J Psychiatry 1988; 145: 413–9

    Google Scholar 

  17. Sauvayre P. The relationship between the court and the doctor on the issue of an inpatient’s refusal of psychotropic medication. J Forensic Sci 1991; 36: 219–25

    PubMed  CAS  Google Scholar 

  18. Gutheil TG. The psychology of psychopharmacology. Bull Menninger Clin 1982; 46: 321–30

    PubMed  CAS  Google Scholar 

  19. Fernando MLD, Manchanda R, Kirk C. Malignant syndrome: a preventative program. J Psychiatry Neurosci 1992; 17: 31–3

    PubMed  CAS  Google Scholar 

  20. Holton SD, Shelton RC, Loosen PT. Cognitive therapy and pharmacotherapy for depression. J Counsel Clin Psychol 1991; 59: 88–99

    Article  Google Scholar 

  21. Michelson LK, Marchione K. Behavioral, cognitive and pharmacological treatment of panic disorder with agoraphobia: critique and synthesis. J Consult Clin Psychol 1991; 59: 100–14

    Article  PubMed  CAS  Google Scholar 

  22. Van Putten T. Why do schizophrenic patients refuse to take their drugs?. Arch Gen Psychiatry 1974; 31: 67–72

    Article  PubMed  Google Scholar 

  23. Blackwell B. Treatment adherence. Br J Psychiatry 1976; 129: 513–31

    Article  PubMed  CAS  Google Scholar 

  24. Kane JM. Prevention and treatment of neuroleptic noncompliance. Psychiatr Ann 1986; 16: 576–9

    Google Scholar 

  25. Shaw E. Lithium noncompliance. Psychiatr Ann 1986; 16: 583–7

    Google Scholar 

  26. Gitlin MJ, Cochran SD, Jamieson KR. Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry 1989; 50: 127–31

    PubMed  CAS  Google Scholar 

  27. Kane JM. Biological, pharmacologic and psychosocial factors influencing response to neuroleptics. Psychopharmacol Bull 1992; 28: 227–9

    PubMed  CAS  Google Scholar 

  28. Lin KM, Poland RE, Smith MW, et al. Pharmacokinetics and other related factors affecting psychotropic response in Asians. Pharmacol Bull 1991; 27: 427–39

    CAS  Google Scholar 

  29. Mendoza R, Smith MW, Poland RE, et al. Ethnic psychopharmacology: the hispanic and Native American perspectives. Psychopharmacol Bull 1991; 27: 449–61

    PubMed  CAS  Google Scholar 

  30. Strickland TL, Ranganath V, Lin KM, et al. Psychopharmacological consideration in the treatment of Black American population. Psychopharmacol Bull 1991; 27: 441–8

    PubMed  CAS  Google Scholar 

  31. Yonkers KA, Kando JC, Cole JO, et al. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medications. Am J Psychiatry 1992; 149: 587–614

    PubMed  CAS  Google Scholar 

  32. Geller JL. State hospital patients and their medication: do they know what they take?. Am J Psychiatry 1982; 139: 611–5

    PubMed  CAS  Google Scholar 

  33. Linden M, Chaskel R. Information and consent in schizophrenic patients in long-term treatment. Schizophr Bull 1981; 7: 372–8

    PubMed  CAS  Google Scholar 

  34. Galloway R, McGuire J. Determinants of compliance with iron supplementation: supplies, side effects or psychology?. Soc Sci Med 1994; 39: 381–90

    Article  PubMed  CAS  Google Scholar 

  35. Chen A. Noncompliance in community psychiatry: a review of clinical interventions. Hosp Community Psychiatry 1991; 42: 282–7

    PubMed  CAS  Google Scholar 

  36. Buckalew LW. Patients’ compliance: the problem and directions for psychological research. Psychol Rep 1991; 68: 348–50

    Article  PubMed  CAS  Google Scholar 

  37. Garrity TF. Medical compliance and the clinician-patient relationship: a review. Soc Sci Med 1981; 15E: 215–22

    Google Scholar 

  38. Meltzer HY. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr Bull 1992; 18: 515–42

    PubMed  CAS  Google Scholar 

  39. Mulaik JS. Noncompliance with medication regimens in severely and persistently mentally ill schizophrenic patients. Issues Ment Health Nurs 1992; 13: 219–37

    Article  PubMed  CAS  Google Scholar 

  40. Prochaska JO, DiClemente CC. The transtheoretical approach. In: Norcross JC, Goldfried MR, editors. Handbook of psychotherapy integration. New York: Basic Books, 1992: 300–34

    Google Scholar 

  41. Parcel GS, Swank PR, Mariotto MJ, et al. Self-management of cystic fibrosis: a structural model for educational and behavioral variables. Soc Sci Med 1994; 38: 1307–15

    Article  PubMed  CAS  Google Scholar 

  42. Putnam DE, Finney JW, Barkley PL, et al. Enhancing commitment improves adherence to a medical regimen. J Consult Clin Psychol 1994; 62: 191–4

    Article  PubMed  CAS  Google Scholar 

  43. Kirchgaessler KU. Illness theory and illness identify: explaining compliance behavior of epileptic patients. In: Greeney JR, Leaf PJ, editors. Research in community and mental health. Greenwich, CT: Jai Press Inc., 1992: 201–35

    Google Scholar 

  44. Goldman CR, Quinn FL. Effects of a patient education program in the treatment of schizophrenia. Hosp Community Psychiatry 1988; 39: 282–6

    PubMed  CAS  Google Scholar 

  45. Brown CS, Wright RG, Christensen DB. Association between type of medication instruction and patients’ knowledge, side effects and compliance. Hosp Community Psychiatry 1987; 38: 55–60

    PubMed  CAS  Google Scholar 

  46. Youssef FA. Adherence to theory in psychiatric patients: an empirical investigation. Int J Nurs Stud 1984; 21: 51–7

    Article  PubMed  CAS  Google Scholar 

  47. Seltzer A, Roncari I, Garfinkel P. Effect of patient education on medication compliance. Can J Psychiatry 1980; 25: 638–45

    PubMed  CAS  Google Scholar 

  48. Myers ED, Calvert EJ. Information, compliance, and side effects: a study of Parkinson antidepressant medications. Br J Clin Pharmacol 1984; 17: 21–5

    Article  PubMed  CAS  Google Scholar 

  49. Cohen MZ, Trip-Reimer T, Smith C, et al. Explanatory models of diabetes: patient practitioner variation. Soc Sci Med 1994; 38: 59–66

    Article  PubMed  CAS  Google Scholar 

  50. Kleinman A. Patients and healers in the context of culture. Berkley, CA: University of California Press, 1980

    Google Scholar 

  51. Tarrier N, Barrowclough C. Providing information to relatives about schizophrenia: some comments. Br J Psychiatry 1986; 149: 458–63

    Article  PubMed  CAS  Google Scholar 

  52. Liberman RP. Social and independent living skills, medication management module: trainer’s manual. Los Angeles: Rehabilitation Research and Training Centre in Mental Illness, 1986

    Google Scholar 

  53. Kopelowicz A, Liberman RP, Wallace CJ. Skills training modules: strategies for dissemination and utilization of a rehabilitation innovation. In: Proceedings of the Schizophrenia Conference; 1994 Aug 21–24: Vancouver, Canada

    Google Scholar 

  54. Klein DF, Davis JM. Diagnosis and drug treatment of psychiatric disorders. Baltimore: Williams and Wilkins, 1969

    Google Scholar 

  55. Rosenstock IM. Historical origins of the health belief model. Health Educ Monogr 1974; 2: 328–35

    Google Scholar 

  56. Becker MH. The health model and sick people behavior. Health Educ Monogr 1974; 2: 409–19

    Google Scholar 

  57. Prochaska JO. Repositioning psychology. In: Proceedings of the Ontario Psychological Association Annual Convention; 1994 Mar 3–6: Toronto, Canada

    Google Scholar 

  58. DiClemente CC, Prochaska JO. Processes and stages of selfchange: coping and competence in smoking behavior change. In: Shiffman S, Wills TA, editors. Coping with substance use. New York: Academic Press, 1985

    Google Scholar 

  59. Zubin J, Spring B. Vulnerability — a new view of schizophrenia. J Abnorm Psychol 1977; 86: 103–26

    Article  PubMed  CAS  Google Scholar 

  60. Falloon I, Boyd J, McGill C. Family care of schizophrenia: a problem-solving approach to the treatment of mental illness. New York: Guilford Press, 1984

    Google Scholar 

  61. Hamera EK, Rhodes RM, Wegner MM. Monitoring of prodromal symptoms: a method for medication management of schizophrenia?. CNS Drugs 1994; 2: 440–52

    Article  Google Scholar 

  62. Kazarian SS, Joseph LW. A brief method for screening outpatients for community-based psychosocial rehabilitation. Hosp Community Psychiatry 1994; 45: 935–7

    PubMed  CAS  Google Scholar 

  63. Kuipers JC, Davidhizar RE. Designing a psychiatric medication education program. J Rehab 1988; 54: 55–61

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Western Ontario, Adult Inpatient Services, London Psychiatric Hospital, 47 Pine Grove Crescent, London, Ontario, N6J 3Y8, Canada

    M. Lakshman D. Fernando

  2. Departments of Psychiatry and Psychology, The University of Western Ontario, London, Ontario, Canada

    Shahe S. Kazarian

  3. Department of Psychological Services, London Psychiatric Hospital, London, Ontario, Canada

    M. Lakshman D. Fernando & Shahe S. Kazarian

Authors
  1. M. Lakshman D. Fernando
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shahe S. Kazarian
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fernando, M.L.D., Kazarian, S.S. Patient Education in the Drug Treatment of Psychiatric Disorders. CNS Drugs 3, 291–304 (1995). https://doi.org/10.2165/00023210-199503040-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199503040-00006

Keywords

Search

Navigation